当前位置:首页 - 行情中心 - 梅花生物(600873) - 财务分析 - 现金流量表

梅花生物

(600873)

  

流通市值:312.10亿  总市值:312.10亿
流通股本:28.53亿   总股本:28.53亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金13,004,397,294.896,460,790,151.4727,266,900,172.1120,292,035,951.86
  收到的税费返还255,379,073.62135,732,651.36590,412,944.2459,602,997.84
  收到其他与经营活动有关的现金191,153,397.33158,096,619.85448,943,253.14355,718,519.67
  经营活动现金流入小计13,450,929,765.846,754,619,422.6828,306,256,369.4521,107,357,469.37
  购买商品、接受劳务支付的现金9,083,489,211.255,141,844,989.2320,140,823,405.614,374,153,645.81
  支付给职工以及为职工支付的现金904,015,836.36483,716,5621,968,598,894.61,531,863,315.08
  支付的各项税费597,189,446.61273,103,809.51859,863,649.52606,174,050.88
  支付其他与经营活动有关的现金553,444,050.99402,686,991.25710,255,629.26509,454,533.85
  经营活动现金流出小计11,138,138,545.216,301,352,351.9923,679,541,578.9817,021,645,545.62
  经营活动产生的现金流量净额2,312,791,220.63453,267,070.694,626,714,790.474,085,711,923.75
二、投资活动产生的现金流量:
  收回投资收到的现金73,892,375.1423,752,887.87190,804,566.6812,840,000
  取得投资收益收到的现金16,498,9797,969,507.5951,309,310.7124,609,930
  处置固定资产、无形资产和其他长期资产收回的现金净额1,245,921.83,707.83,487,009.21,237,196
  投资活动现金流入小计91,637,275.9431,726,103.26245,600,886.5938,687,126
  购建固定资产、无形资产和其他长期资产支付的现金1,087,107,997.28552,920,288.672,004,423,105.691,425,811,689.2
  投资支付的现金1,944,967,826.41,629,455,144881,089,058.612,342,886,143.38
  支付其他与投资活动有关的现金2,859,048.14472,5009,047,530-
  投资活动现金流出小计3,034,934,871.822,182,847,932.672,894,559,694.33,768,697,832.58
  投资活动产生的现金流量净额-2,943,297,595.88-2,151,121,829.41-2,648,958,807.71-3,730,010,706.58
三、筹资活动产生的现金流量:
  取得借款收到的现金2,874,965,205.641,459,109,699.946,297,183,657.374,914,588,328.04
  收到其他与筹资活动有关的现金428,515,211.85165,062,467.78389,646,523.23287,772,154.46
  筹资活动现金流入小计3,303,480,417.491,624,172,167.726,686,830,180.65,202,360,482.5
  偿还债务支付的现金2,629,070,0001,253,360,0006,411,943,930.695,106,015,680.69
  分配股利、利润或偿付利息支付的现金1,228,810,522.7612,265,180.311,789,239,618.911,268,690,731.64
  支付其他与筹资活动有关的现金255,748,337.46182,309,929.841,223,698,914.69670,263,213.09
  筹资活动现金流出小计4,113,628,860.221,447,935,110.159,424,882,464.297,044,969,625.42
  筹资活动产生的现金流量净额-810,148,442.73176,237,057.57-2,738,052,283.69-1,842,609,142.92
四、汇率变动对现金及现金等价物的影响31,539,177.2322,189,675.61111,541,460.3471,035,361.96
五、现金及现金等价物净增加额-1,409,115,640.75-1,499,428,025.54-648,754,840.59-1,415,872,563.79
  加:期初现金及现金等价物余额4,131,859,602.144,131,859,602.264,780,614,442.734,780,614,442.73
  期末现金及现金等价物余额2,722,743,961.392,632,431,576.724,131,859,602.143,364,741,878.94
补充资料:
  净利润1,767,950,116.89-2,740,427,215.56-
  资产减值准备9,236,606.64-6,981,927.26-
  固定资产和投资性房地产折旧663,310,890.94-1,275,227,848.29-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧663,310,890.94-1,275,227,848.29-
  无形资产摊销20,437,708.39-45,749,650.73-
  长期待摊费用摊销18,080,269.41-36,976,072.81-
  处置固定资产、无形资产和其他长期资产的损失-438,552.05--29,968.32-
  固定资产报废损失6,570,163.08-34,405,586.69-
  公允价值变动损失-16,016,844.67--14,826,169.53-
  财务费用-737,611.57--29,377,272.58-
  投资损失-29,250,766.79--30,193,009.09-
  递延所得税-20,007,640.1-15,127,342.15-
  其中:递延所得税资产减少-19,972,579.93-14,034,060.21-
    递延所得税负债增加-35,060.17-1,093,281.94-
  存货的减少208,943,971.2-202,965,494.39-
  经营性应收项目的减少-3,689,852.79-306,096,165.23-
  经营性应付项目的增加-313,556,197.56-37,357,071.5-
  现金的期末余额2,722,743,961.39-4,131,859,602.14-
  减:现金的期初余额4,131,859,602.14-4,780,614,442.73-
  现金及现金等价物的净增加额-1,409,115,640.75--648,754,840.59-
公告日期2025-08-202025-04-222025-03-182024-10-23
审计意见(境内)标准无保留意见
TOP↑